Showing results (611-620 of 9,668) with videos related to
Sort By:
Pageof 967
Leukemia|April 9, 2010
Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myelomaA Palumbo, A Larocca, P Falco, et al.Leukemia|May 21, 2010
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutationsM M Patnaik, T L Lasho, C M Finke, et al.Leukemia|April 23, 2010
High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progressionJ Boultwood, J Perry, R Zaman, et al.Leukemia|May 29, 2010
Deletions of the transcription factor Ikaros in myeloproliferative neoplasmsR Jäger, H Gisslinger, F Passamonti, et al.Leukemia|May 29, 2010
Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradationM Buchwald, K Pietschmann, J P Müller, et al.Leukemia|May 8, 2009
A novel treatment strategy targeting polo-like kinase 1 in hematological malignanciesT Ikezoe, J Yang, C Nishioka, et al.Leukemia|August 7, 2009
Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofolliclesM Plander, S Seegers, P Ugocsai, et al.Leukemia|September 1, 1991
Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literatureH J Adriaansen, P W Soeting, I L Wolvers-Tettero, et al.Leukemia|September 1, 1991
Interferon gamma induces differentiation of cells from patients with myelodysplastic syndromes in vitro and in vivoY YoshidaLeukemia|May 14, 2009
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophagesA Carbonnelle-Puscian, C Copie-Bergman, M Baia, et al.Pageof 967